227
Participants
Start Date
December 31, 2003
Primary Completion Date
December 31, 2005
Study Completion Date
December 31, 2005
Fluticasone propionate/salmeterol
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Altoona
GSK Investigational Site, Upland
GSK Investigational Site, Bethesda
GSK Investigational Site, Burke
GSK Investigational Site, Kernersville
GSK Investigational Site, Orangeburg
GSK Investigational Site, Charleston
GSK Investigational Site, Mt. Pleasant
GSK Investigational Site, Lawrenceville
GSK Investigational Site, Marietta
GSK Investigational Site, Savannah
GSK Investigational Site, Savannah
GSK Investigational Site, Altamonte Springs
GSK Investigational Site, Delray Beach
GSK Investigational Site, Tampa
GSK Investigational Site, Tampa
GSK Investigational Site, St. Petersburg
GSK Investigational Site, Louisville
GSK Investigational Site, Iowa City
GSK Investigational Site, Robbinsdale
GSK Investigational Site, Missoula
GSK Investigational Site, Normal
GSK Investigational Site, Omaha
GSK Investigational Site, Sunset
GSK Investigational Site, Jonesboro
GSK Investigational Site, Oklahoma City
GSK Investigational Site, Dallas
GSK Investigational Site, Houston
GSK Investigational Site, San Antonio
GSK Investigational Site, El Paso
GSK Investigational Site, El Paso
GSK Investigational Site, Englewood
GSK Investigational Site, Denver
GSK Investigational Site, Pueblo
GSK Investigational Site, Layton
GSK Investigational Site, Provo
GSK Investigational Site, Los Angeles
GSK Investigational Site, Rolling Hills Est
GSK Investigational Site, East Artesia
GSK Investigational Site, Long Beach
GSK Investigational Site, Vista
GSK Investigational Site, Huntington Beach
GSK Investigational Site, Mission Viejo
GSK Investigational Site, Madera
GSK Investigational Site, Oakland
GSK Investigational Site, Medford
GSK Investigational Site, Boston
GSK Investigational Site, Mount Laurel
GSK Investigational Site, Nashville
GSK Investigational Site, South Burlington
Lead Sponsor
GlaxoSmithKline
INDUSTRY